These in vitro findings are supported by reports about the high levels of syndecan-1 (SDC-1) in convalescent patients (Vollenberg et al., 2021), suggesting that endothelial damage persists during COVID-19 progression, and highlights an important role in long COVID and possibly of the spike protein, given its persistence in circulation after acute infection. The gene discussed is SDC1; the disease is COVID-19.